Debt / equity moved 8050 bp lower
Debt / equity changed -8050 basis points from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
262.60%→182.09%4 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →BMY financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating cash-flow margin moved 1964 bp lower
Operating cash-flow margin changed -1964 basis points from the comparable as-filed period.
51.64%→31.99%2 prior comparisons
Free-cash-flow margin moved 1966 bp lower
Free-cash-flow margin changed -1966 basis points from the comparable as-filed period.
49.02%→29.36%2 prior comparisons
Debt / revenue moved 7251 bp lower
Debt / revenue changed -7251 basis points from the comparable as-filed period.
398.60%→326.09%2 prior comparisons
Shares outstanding increased 0.4%
Shares outstanding changed +0.4% from the comparable as-filed period. The change ranks at the 75th percentile of 8 prior comparable changes.
2,035,753,027→2,044,085,8318 prior comparisons
Gross debt decreased 12.5%
Gross debt changed -12.5% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$48.7B→$42.6B4 prior comparisons
Reported total debt decreased 12.5%
Reported total debt changed -12.5% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$48.7B→$42.6B4 prior comparisons
Operating cash flow / net income decreased 32.6%
Operating cash flow / net income changed -32.6% from the comparable as-filed period.
2.87→1.930 prior comparisons
Receivables / revenue moved 841 bp lower
Receivables / revenue changed -841 basis points from the comparable as-filed period.
78.74%→70.33%2 prior comparisons
Debt / assets moved 227 bp lower
Debt / assets changed -227 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
50.28%→48.01%4 prior comparisons
Inventory / revenue moved 188 bp lower
Inventory / revenue changed -188 basis points from the comparable as-filed period.
22.57%→20.69%2 prior comparisons
Cost of revenue increased 20.7%
Cost of revenue changed +20.7% from the comparable as-filed period.
$3.4B→$4.1B2 prior comparisons
R&D / revenue moved 259 bp lower
R&D / revenue changed -259 basis points from the comparable as-filed period.
20.68%→18.10%2 prior comparisons
Revenue increased 6.9%
Revenue changed +6.9% from the comparable as-filed period.
$12.2B→$13.1B2 prior comparisons
Noncurrent long-term debt decreased 5.9%
Noncurrent long-term debt changed -5.9% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$44.5B→$41.8B4 prior comparisons
Research & development decreased 6.4%
Research & development changed -6.4% from the comparable as-filed period.
$2.5B→$2.4B2 prior comparisons
Capex / revenue moved 1 bp higher
Capex / revenue changed +1 basis points from the comparable as-filed period.
2.62%→2.63%2 prior comparisons
Capital expenditure increased 7.5%
Capital expenditure changed +7.5% from the comparable as-filed period.
$320.0M→$344.0M2 prior comparisons
Net income decreased 1.8%
Net income changed -1.8% from the comparable as-filed period.
$2.2B→$2.2B2 prior comparisons
Trade receivables decreased 4.5%
Trade receivables changed -4.5% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$9.6B→$9.2B4 prior comparisons
SBC / revenue moved 8 bp lower
SBC / revenue changed -8 basis points from the comparable as-filed period.
1.14%→1.06%2 prior comparisons
Net debt increased 0.2%
Net debt changed +0.2% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
$33.0B→$33.0B4 prior comparisons
Selling, general & administrative decreased 5.0%
Selling, general & administrative changed -5.0% from the comparable as-filed period.
$1.8B→$1.7B2 prior comparisons
Inventory decreased 2.0%
Inventory changed -2.0% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$2.8B→$2.7B4 prior comparisons
Stock-based compensation decreased 0.7%
Stock-based compensation changed -0.7% from the comparable as-filed period.
$139.0M→$138.0M2 prior comparisons
Free-cash-flow proxy decreased 13.2%
Free-cash-flow proxy changed -13.2% from the comparable as-filed period.
$3.6B→$3.1B3 prior comparisons
Operating cash flow decreased 13.4%
Operating cash flow changed -13.4% from the comparable as-filed period.
$3.9B→$3.4B3 prior comparisons
Debt / equity moved 8869 bp lower
Debt / equity changed -8869 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
280.73%→192.04%4 prior comparisons
Gross margin moved 124 bp lower
Gross margin changed -124 basis points from the comparable as-filed period.
72.52%→71.28%2 prior comparisons
Debt / assets moved 279 bp lower
Debt / assets changed -279 basis points from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
51.70%→48.91%4 prior comparisons
Debt / revenue moved 6855 bp lower
Debt / revenue changed -6855 basis points from the comparable as-filed period.
398.93%→330.39%2 prior comparisons
Cash / debt moved 539 bp lower
Cash / debt changed -539 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
25.74%→20.35%4 prior comparisons
Free-cash-flow margin moved 518 bp lower
Free-cash-flow margin changed -518 basis points from the comparable as-filed period.
28.98%→23.80%2 prior comparisons
Operating cash-flow margin moved 577 bp lower
Operating cash-flow margin changed -577 basis points from the comparable as-filed period.
31.93%→26.15%2 prior comparisons
Receivables / revenue moved 918 bp lower
Receivables / revenue changed -918 basis points from the comparable as-filed period.
79.15%→69.97%2 prior comparisons
Operating cash flow / net income decreased 65.8%
Operating cash flow / net income changed -65.8% from the comparable as-filed period.
2.99→1.020 prior comparisons
Gross debt decreased 12.4%
Gross debt changed -12.4% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$48.9B→$42.9B4 prior comparisons
Reported total debt decreased 12.4%
Reported total debt changed -12.4% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$48.9B→$42.9B4 prior comparisons
Revenue increased 5.7%
Revenue changed +5.7% from the comparable as-filed period.
$12.3B→$13.0B2 prior comparisons
Capital expenditure decreased 15.5%
Capital expenditure changed -15.5% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$361.0M→$305.0M3 prior comparisons
Trade receivables decreased 6.5%
Trade receivables changed -6.5% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$9.7B→$9.1B4 prior comparisons
Research & development increased 14.7%
Research & development changed +14.7% from the comparable as-filed period.
$2.6B→$3.0B2 prior comparisons
Net debt decreased 6.1%
Net debt changed -6.1% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$36.3B→$34.1B4 prior comparisons
Noncurrent long-term debt decreased 5.3%
Noncurrent long-term debt changed -5.3% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$44.5B→$42.1B4 prior comparisons
Inventory / revenue moved 121 bp lower
Inventory / revenue changed -121 basis points from the comparable as-filed period.
22.31%→21.10%2 prior comparisons
Shares outstanding increased 0.4%
Shares outstanding changed +0.4% from the comparable as-filed period. The change ranks at the 38th percentile of 8 prior comparable changes.
2,035,435,838→2,042,714,6568 prior comparisons
Capex / revenue moved 59 bp lower
Capex / revenue changed -59 basis points from the comparable as-filed period.
2.94%→2.35%2 prior comparisons
R&D / revenue moved 178 bp higher
R&D / revenue changed +178 basis points from the comparable as-filed period.
21.03%→22.81%2 prior comparisons
Cost of revenue increased 10.5%
Cost of revenue changed +10.5% from the comparable as-filed period.
$3.4B→$3.7B2 prior comparisons
SBC / revenue moved 8 bp lower
SBC / revenue changed -8 basis points from the comparable as-filed period.
1.12%→1.04%2 prior comparisons
Selling, general & administrative increased 6.6%
Selling, general & administrative changed +6.6% from the comparable as-filed period.
$1.7B→$1.8B2 prior comparisons
Stock-based compensation decreased 2.2%
Stock-based compensation changed -2.2% from the comparable as-filed period.
$138.0M→$135.0M2 prior comparisons
Inventory unchangedd 0.0%
Inventory changed +0.0% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$2.7B→$2.7B4 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.